Skip to main content Skip to main navigation menu Skip to site footer


Abstract

Background: Coronavirus disease (COVID-19) caused by the SARS-CoV-2 virus started in Wuhan, China, spreading rapidly to various countries. This literature review aims to provide an overview, diagnosis and management of COVID-19 in children.

Methods: In this paper, the literature review method is used. Sources of reading come from relevant and appropriate journals and books from PubMed, Ebsco and Proquest.

Results: Based on data from the Indonesian Ministry of Health dated January 15, 2021, it shows that 2.7% of confirmed cases of COVID-19 are children aged 0-5 years, and 8.9% children aged 6- 18 years. The mortality rate for COVID-19 in children aged 0-5 years is 0.8% and aged 6-18 years is around 1.5%. The most common pattern of transmission of COVID-19 to children is from family clusters. Symptoms and signs of COVID-19 in children include fever, cough, rhinorrhea, painful swallowing, weakness, lacrimation, headache, diarrhea, vomiting, cyanosis and in severe cases Multisystem Inflammatory Syndrome COVID-19 (MIS-C). Diagnosis of COVID-19 in children is confirmed from clinical symptoms and supportive laboratory results such as low to normal leukocytes, increased CRP and radiological abnormalities such as hazy opacities on X rays and ground glass appearance on thoracic computed tomography (CT), despite Real Time Polymerase Chain Reaction ( RT-PCR) is the standard method for diagnosing this disease. General management of children with COVID-19 in the form of complete rest, supportive therapy, symptomatic therapy, administration of vitamins and monitoring of vital signs and oxygen supplementation. Antiviral therapy, antibiotics and steroids are given as indicated. The COVID-19 vaccine for children is currently in the process of being researched.

Conclusion: The COVID-19 pandemic is spreading rapidly, and confirmed cases in children are increasing significantly. The prevalence of COVID-19 in children tends to be lower and most of them have milder symptoms than adults, but proper diagnosis and management is needed.

 

 

Latar Belakang: Coronavirus disease (COVID-19) disebabkan oleh virus SARS-CoV-2 diawali di Wuhan, Cina menyebar dengan cepat ke berbagai negara. Tinjauan pustaka ini bertujuan memberikan gambaran, diagnosis dan tatalaksana COVID-19 anak.

Metode: Dalam penulisan ini digunakan metode tinjauan pustaka. Sumber bacaan berasal jurnal-jurnal dan buku relevan dan sesuai dari PubMed, Ebsco dan Proquest.

Hasil: Berdasarkan data Kementrian Kesehatan Indonesia tanggal 15 Januari 2021 menujukkan 2,7 % kasus terkonfirmasi COVID-19 adalah anak usia 0-5 tahun, dan 8,9% anak usia 6- 18 tahun. Angka Kematian COVID-19 pada anak usia 0-5 tahun adalah 0,8% dan usia 6-18 tahun sekitar 1,5%. Pola tersering penularan COVID-19 pada anak adalah berasal dari kluster keluarga. Gejala dan tanda COVID-19 pada anak meliputi demam, batuk, rhinorrhea, nyeri menelan, lemas, lakrimasi, nyeri kepala, diare, muntah, sianosis dan pada kasus berat terjadi Multisystem Inflammatory Syndrome COVID-19 (MIS-C). Diagnosa COVID-19 anak ditegakkan dari gejala klinis dan hasil laboratorium mendukung seperti leukosit yang rendah ke normal, peningkatan CRP dan abnormalitas radiologis seperti hazy opacities pada X ray dan ground glass appearance pada Computed Tomography (CT) toraks, meskipun Real Time Polymerase Chain Reaction (RT-PCR) merupakan metode baku untuk menegakkan diagnosis penyakit ini. Tatalaksana umum pasien COVID-19 anak berupa istirahat total, terapi suportif, terapi simtomatik, pemberian vitamin serta pemantauan tanda vital dan suplementasi oksigen. Terapi antivirus, antibiotik, dan steroid diberikan sesuai indikasi. Vaksin COVID-19 anak saat ini masih dalam proses penelitian.

Kesimpulan: Pandemi COVID-19 meyebar dengan cepat, dan kasus terkonfirmasi pada anak meningkat secara signifikan. Prevalensi COVID-19 anak cenderung lebih rendah dan sebagian besar memiliki gejala yang lebih ringan dibanding dewasa namun diagnosis dan tatalaksana yang tepat sangat diperlukan.

Keywords: COVID-19 SARS-CoV-2 pediatrik

References

  1. World Health Organization. WHO Timeline - COVID-19 [Internet]. WHO Press. 2020. Available from: https://www.who.int/news/item/27-04-2020-who-timeline---covid-19
  2. Shah SGS, Farrow A. A commentary on “World Health Organization declares global emergency: A review of the 2019 novel Coronavirus (COVID-19).” Int J Surg. 2020/03/10. 2020;76:128–9. Available from: https://pubmed.ncbi.nlm.nih.gov/32169574
  3. World Health Organization. Indonesia Country Overview | World Health Organization [Internet]. WHO. 2021. Available from: https://covid19.who.int/region/searo/country/id
  4. Yoldas MA, Yoldas H. Pediatric COVID-19 Disease: A Review of the Recent Literature. Pediatr Ann. 2020;49(7). Available from: http://dx.doi.org/10.3928/19382359-20200615-01
  5. Satgas COVID 19. Situasi Virus Corona - Covid19.go.id [Internet]. Satgas COVID 19. 2021. Available from: https://data.covid19.go.id/public/index.html
  6. Guo C-X, He L, Yin J-Y, Meng X-G, Tan W, Yang G-P, et al. Epidemiological and clinical features of pediatric COVID-19. BMC Med. 2020;18(1):1–7.
  7. Patel NA. Pediatric COVID-19: Systematic review of the literature. Am J Otolaryngol. 2020/06/06. 2020;41(5):102573. Available from: https://pubmed.ncbi.nlm.nih.gov/32531620
  8. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020/02/07. 2020;92(4):418–23. Available from: https://pubmed.ncbi.nlm.nih.gov/31967327
  9. Jiehao C, Jin X, Daojiong L, Zhi Y, Lei X, Zhenghai Q, et al. A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features. Clin Infect Dis. 2020;71(6):1547–51. Available from: https://pubmed.ncbi.nlm.nih.gov/32112072
  10. Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020/04/27. 2020;20(8):911–9. Available from: https://pubmed.ncbi.nlm.nih.gov/32353347
  11. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020/03/17. 2020;382(16):1564–7. Available from: https://pubmed.ncbi.nlm.nih.gov/32182409
  12. Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for Gastrointestinal Infection of SARS-CoV-2. Gastroenterology. 2020/03/03. 2020;158(6):1831-1833.e3. Available from: https://pubmed.ncbi.nlm.nih.gov/32142773
  13. Foust AM, McAdam AJ, Chu WC, Garcia-Peña P, Phillips GS, Plut D, et al. Practical guide for pediatric pulmonologists on imaging management of pediatric patients with COVID-19. Pediatr Pulmonol. 2020/07/01. 2020;55(9):2213–24. Available from: https://pubmed.ncbi.nlm.nih.gov/32462724
  14. Wu H, Zhu H, Yuan C, Yao C, Luo W, Shen X, et al. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China. JAMA Netw open. 2020;3(6):e2010895–e2010895. Available from: https://pubmed.ncbi.nlm.nih.gov/32492165
  15. Tam H, El Tal T, Go E, Yeung RSM. Pediatric inflammatory multisystem syndrome temporally associated with COVID-19: a spectrum of diseases with many names. CMAJ. 2020/09/09. 2020;192(38):E1093–6. Available from: https://pubmed.ncbi.nlm.nih.gov/32907819
  16. Shahbaznejad L, Navaeifar MR, Abbaskhanian A, Hosseinzadeh F, Rahimzadeh G, Rezai MS. Clinical characteristics of 10 children with a pediatric inflammatory multisystem syndrome associated with COVID-19 in Iran. BMC Pediatr. 2020;20(1):513. Available from: https://pubmed.ncbi.nlm.nih.gov/33167916
  17. World Health Organization. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19 [Internet]. WHO Press. 2020. Available from: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19
  18. PDPI, PERKI, PAPDI, PERDATIN, IDAI. Buku Pedoman Tatalaksana COVID-19. 3rd ed. Jakarta: IDAI; 2020.
  19. CDC. Centers for Disease Control and Prevention [Internet]. 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/testing.html
  20. World Health Organization. Implementation of Antigen RDT (Ag-RDT) to detect COVID-19 cases in Indonesia [Internet]. WHO. 2020. Available from: ttps://www.who.int/indonesia/news/detail/08-12-2020-implementation-of-antigen-rdt-(ag-rdt)-to-detect-covid-19-cases-in-indonesia
  21. COVID L. RT-PCR test EUA Summary. Accel Emerg Use Auth Summ COVID-19 RT-PCR Test (Laboratory Corp Am Available online www fda gov (accessed 20 March 2020). 19AD;
  22. World Health Organization. Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays [Internet]. WHO. 2020. Available from: https://www.who.int/publications-detail-redirect/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays
  23. Arslan G, Aktürk H, Duman M. Clinical Characteristics of Pediatric COVID-19 and Predictors of PCR Positivity. Pediatr Int. 2021;10.1111/ped.14602. Available from: https://pubmed.ncbi.nlm.nih.gov/33426754
  24. Shen K-L, Yang Y-H. Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue. World J Pediatr. 2020/02/05. 2020;16(3):219–21. Available from: https://pubmed.ncbi.nlm.nih.gov/32026147
  25. Wati DK, Manggala AK. Overview of management of children with COVID-19. Clin Exp Pediatr. 2020/07/17. 2020;63(9):345–54. Available from: https://pubmed.ncbi.nlm.nih.gov/32683801
  26. NIH. COVID-19 Treatment Guidelines [Internet]. US Gov. 2020. Available from: https://www.covid19treatmentguidelines.nih.gov/special-populations/children/
  27. AAP. COVID-19 Vaccine: Frequently Asked Questions [Internet]. AAP. 2020. Available from: http://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/covid-19-vaccine-frequently-asked-questions/
  28. Badan Pengawas Obat dan Makanan. Penerbitan Persetujuan Penggunaan Dalam Kondisi Darurat Atau Emergency Use Authorization Pertama Untuk Vaksin COVID-19 [Internet]. Republik Indonesia. 2021. Available from: https://www.pom.go.id/new/view/more/pers/584/Penerbitan-Persetujuan-Penggunaan-Dalam-Kondisi-Darurat-Atau-Emergency-Use-Authorization--EUA--Pertama-Untuk-Vaksin-COVID-19.html

How to Cite

Hadiyanto, M. L. (2021). Gambaran hingga tatalaksana COVID-19 pada anak. Intisari Sains Medis, 12(1), 250–255. https://doi.org/10.15562/ism.v12i1.947
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
1346

Total
2665

Share

Search Panel

Marissa Leviani Hadiyanto
Google Scholar
Pubmed
ISM Journal